ESC Professional Premium Access

Intravascular imaging / physiology: guiding PCI to improve outcomes

Event: ESC Congress 2022
Topic: Invasive Imaging and Functional Assessment
Session type: Moderated ePosters
Date: 26 August 2022
Time: 10:15 - 10:55

Congress Session

6 presentations in this session

Changes in high-sensitivity troponin according to optical characteristics of neointima and treatment modality of in-stent restenosis

Speaker: Doctor N. Nano (Munich, DE)
Thumbnail

Clinical relevance of impaired physiological assessment after percutaneous coronary intervention: a meta-analysis

Speaker: Professor R. van Geuns (Nijmegen, NL)
Thumbnail

Side effects and major adverse cardiac events caused by fractional flow reserve measurement: a systematic review and meta-analysis of 12,215 patients

Speaker: Mr J. Altstidl (Erlangen, DE)
Thumbnail

Correlation of FFR measured after DES implantation with clinical parameters and long-term clinical outcome

Speaker: Doctor B. Csanadi (Budapest, HU)
Thumbnail

Angiographic derived physiological assessment after intervention for predicting 2-year vessel-oriented composite endpoints in Multivessel TALENT trial

Speaker: Doctor S. KAGEYAMA (Galway, IE)
Thumbnail

Pathological analysis of struts coverage after second- and third-generation drug-eluting stents implantation for duration of dual anti-platelets therapy; an autopsy study

Speaker: Mr K. Aihara (Kanagawa, JP)
Thumbnail

6 speakers from this session

Doctor Nejva Nano

German Heart Center of Munich, Munich (Germany)
0 follower

Professor Robert-Jan Matthijs van Geuns

Radboud University Medical Centre, Nijmegen (Netherlands (The))
0 follower

Mr Johannes Michael Altstidl

Friedrich-Alexander University of Erlangen-Nuremberg, Erlangen (Germany)
0 follower

Doctor Bettina Csanadi

Gottsegen National Cardiovascular Center, Budapest (Hungary)
0 follower

Doctor Shigetaka KAGEYAMA

National University of Ireland, Galway (Ireland)
0 follower

Mr Kazuki Aihara

Tokai University School of Medicine, Kanagawa (Japan)
0 follower

This platform is supported by

logo Novo Nordisk